HOME >> MEDICINE >> NEWS
Selective and nonselective beta-blockers equally effective in preventing sudden death

DALLAS - September 2, 1999 - A new study from UT Southwestern Medical Center at Dallas should encourage cardiologists to prescribe either selective or nonselective beta-blockers to patients with congestive heart failure. Researchers found both types of drugs equally effective in reducing the risk of sudden death.

In a study of 26 patients with congestive heart failure, researchers from UT Southwestern and Dallas Veterans Affairs Medical Center found no difference in the reduction of QTc dispersion -- a marker of risk for sudden death -- between those treated with selective beta-blockers and those treated with nonselective beta-blockers. Their findings were published in the August issue of The American Journal of Cardiology.

The scientists compared the electrocardiograms (ECG) of the patients before and after three months of therapy with either a selective beta-blocker, which inhibits the beta 1 receptor, or a nonselective beta-blocker, which inhibits both the beta 1 and the beta 2 receptors.

Congestive heart failure kills more than 43,000 people in the United States annually. A number of recent studies have shown that physicians underprescribe beta-blockers because of their side effects despite clinical-trial reports that congestive-heart-failure patients who take them are 43 percent less likely to die during the first two years following a first heart attack than those who do not take them. Side effects may include depression, worsening asthma, tiredness and sexual dysfunction, although many physicians note that the heart attack itself may produce these.

"This is significant because it gives us a better idea of how effective different beta-blockers are in treating congestive heart failure," said Dr. Eric Eichhorn, UT Southwestern professor of internal medicine and director of the cardiac catheterization laboratory at the VA Medical Center. "The findings give doctors more options in treating their patients and help us a
'"/>

Contact: Susan Steeves
susan.steeves@email.swmed.edu
214-648-3404
UT Southwestern Medical Center
31-Aug-1999


Page: 1 2

Related medicine news :

1. Selective coatings create biological sensors from carbon nanotubes
2. Selective inhibitor can target specific enzyme that promotes cancer
3. In heart failure, beta-blockers boost survival advantage for women
4. Wider use of beta-blockers after heart attacks could save thousands of lives at a reasonable cost, new study shows
5. Aspirins potential ability to prevent colon polyps may not apply equally to all
6. New guidelines conclude all aerosol therapy devices equally effective
7. Baby and coated aspirin equally effective in thinning of blood when taken in combination with Plavix
8. Beta-blocker or calcium antagonist-based therapies equally effective in treating hypertension
9. Smoking cessation success equally good with over-the-counter or prescription nicotine replacement
10. Strategy effective against drug resistant tuberculosis
11. Study shows patch therapy may be as effective as oral medications

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 13, 2017 , ... PurhealthRX , a leading Health and Nutrition Company, ... Purzorb™process to full spectrum CBD oil will revolutionize the rapidly growing CBD market by ... be easily incorporated into liquid products, while reducing costs to end users. , The ...
(Date:10/13/2017)... ... October 13, 2017 , ... The Visiting Nurse Association (VNA) ... a collection of specialty vendors and unique items from across the nation, this holiday-themed ... and wellness services offered by the VNA. The boutique will be open Saturday, ...
(Date:10/13/2017)... Fairfax, VA (PRWEB) , ... October 13, 2017 ... ... provider of DevOps and Agile Software Development, has been awarded a contract by ... (EATS) Blanket Purchase Agreement (BPA) aims to accelerate the enterprise use of Agile ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... the Centers for Disease Control and Prevention (CDC), influenza vaccination should ... helping communities across Massachusetts , Connecticut ... shots through the end of the month. *Some exclusions apply ... ... is by the end of October, according to the Centers for Disease ...
(Date:10/2/2017)... 2, 2017 Diplomat Pharmacy, Inc. (NYSE: ... and Consulting, LLC , and named its founder as ... in Tennessee , will operate under ... EnvoyHealth,s service offerings for health care partners to include ... "In an interoperable world, technology delivers ...
(Date:10/2/2017)... 2017  AllianceRx Walgreens Prime, the combined central specialty ... pharmacy benefit manager Prime Therapeutics LLC (Prime), today officially ... the unveiling of new signage at its headquarters in ... at a few other company-owned facilities across the country. ... some of whom will begin to see the AllianceRx ...
Breaking Medicine Technology:
Cached News: